These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8807831)

  • 21. Identification of natural ligands for SH2 domains from a phage display cDNA library.
    Cochrane D; Webster C; Masih G; McCafferty J
    J Mol Biol; 2000 Mar; 297(1):89-97. PubMed ID: 10704309
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of B cell signal transduction by SH2-containing protein-tyrosine phosphatases.
    Siminovitch KA; Neel BG
    Semin Immunol; 1998 Aug; 10(4):329-47. PubMed ID: 9695189
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BIAcore analysis to test phosphopeptide-SH2 domain interactions.
    Vély F; Trautmann A; Vivier E
    Methods Mol Biol; 2000; 121():313-21. PubMed ID: 10818737
    [No Abstract]   [Full Text] [Related]  

  • 24. Immunoreceptor tyrosine-based inhibitory motif of the IL-4 receptor associates with SH2-containing phosphatases and regulates IL-4-induced proliferation.
    Kashiwada M; Giallourakis CC; Pan PY; Rothman PB
    J Immunol; 2001 Dec; 167(11):6382-7. PubMed ID: 11714803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protein tyrosine phosphatases: mechanisms of catalysis and regulation.
    Denu JM; Dixon JE
    Curr Opin Chem Biol; 1998 Oct; 2(5):633-41. PubMed ID: 9818190
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Solution structure of the C-terminal SH2 domain of the human tyrosine kinase Syk complexed with a phosphotyrosine pentapeptide.
    Narula SS; Yuan RW; Adams SE; Green OM; Green J; Philips TB; Zydowsky LD; Botfield MC; Hatada M; Laird ER
    Structure; 1995 Oct; 3(10):1061-73. PubMed ID: 8590001
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD150 association with either the SH2-containing inositol phosphatase or the SH2-containing protein tyrosine phosphatase is regulated by the adaptor protein SH2D1A.
    Shlapatska LM; Mikhalap SV; Berdova AG; Zelensky OM; Yun TJ; Nichols KE; Clark EA; Sidorenko SP
    J Immunol; 2001 May; 166(9):5480-7. PubMed ID: 11313386
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Shp-2 tyrosine phosphatase: signaling one cell or many.
    Feng GS
    Exp Cell Res; 1999 Nov; 253(1):47-54. PubMed ID: 10579910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanistic studies on full length and the catalytic domain of the tandem SH2 domain-containing protein tyrosine phosphatase: analysis of phosphoenzyme levels and Vmax stimulatory effects of glycerol and of a phosphotyrosyl peptide ligand.
    Wang J; Walsh CT
    Biochemistry; 1997 Mar; 36(10):2993-9. PubMed ID: 9062130
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SH2 domain-mediated interaction of inhibitory protein tyrosine kinase Csk with protein tyrosine phosphatase-HSCF.
    Wang B; Lemay S; Tsai S; Veillette A
    Mol Cell Biol; 2001 Feb; 21(4):1077-88. PubMed ID: 11158295
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Crystal structure and NMR studies of the apo SH2 domains of ZAP-70: two bikes rather than a tandem.
    Folmer RH; Geschwindner S; Xue Y
    Biochemistry; 2002 Dec; 41(48):14176-84. PubMed ID: 12450381
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure and function of SH2-domain containing tyrosine phosphatases.
    Neel BG
    Semin Cell Biol; 1993 Dec; 4(6):419-32. PubMed ID: 8305681
    [TBL] [Abstract][Full Text] [Related]  

  • 33. B cell antigen receptor (BCR)-mediated formation of a SHP-2-pp120 complex and its inhibition by Fc gamma RIIB1-BCR coligation.
    Nakamura K; Cambier JC
    J Immunol; 1998 Jul; 161(2):684-91. PubMed ID: 9670943
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Negative regulation of FcepsilonRI signaling by FcgammaRII costimulation in human blood basophils.
    Kepley CL; Cambier JC; Morel PA; Lujan D; Ortega E; Wilson BS; Oliver JM
    J Allergy Clin Immunol; 2000 Aug; 106(2):337-48. PubMed ID: 10932079
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A yeast two-hybrid study of human p97/Gab2 interactions with its SH2 domain-containing binding partners.
    Crouin C; Arnaud M; Gesbert F; Camonis J; Bertoglio J
    FEBS Lett; 2001 Apr; 495(3):148-53. PubMed ID: 11334882
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The specificity of the N-terminal SH2 domain of SHP-2 is modified by a single point mutation.
    Huyer G; Ramachandran C
    Biochemistry; 1998 Mar; 37(9):2741-7. PubMed ID: 9485424
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SH2-Containing protein tyrosine phosphatase-1 (SHP-1) association with Jak2 in UT-7/Epo cells.
    Wu DW; Stark KC; Dunnington D; Dillon SB; Yi T; Jones C; Pelus LM
    Blood Cells Mol Dis; 2000 Feb; 26(1):15-24. PubMed ID: 10772872
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Specificity of the SH2 domains of SHP-1 in the interaction with the immunoreceptor tyrosine-based inhibitory motif-bearing receptor gp49B.
    Wang LL; Blasioli J; Plas DR; Thomas ML; Yokoyama WM
    J Immunol; 1999 Feb; 162(3):1318-23. PubMed ID: 9973385
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of immune function by protein tyrosine phosphatases.
    Okumura M; Thomas ML
    Curr Opin Immunol; 1995 Jun; 7(3):312-9. PubMed ID: 7546394
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytoplasmic protein tyrosine phosphatases SHP-1 and SHP-2: regulators of B cell signal transduction.
    Tamir I; Dal Porto JM; Cambier JC
    Curr Opin Immunol; 2000 Jun; 12(3):307-15. PubMed ID: 10781410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.